Your browser doesn't support javascript.
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer.
McKenzie, Duncan R; Muñoz-Ruiz, Miguel; Monin, Leticia; Alaguthurai, Thanussuyah; Lechmere, Thomas; Abdul-Jawad, Sultan; Graham, Carl; Pollock, Emily; Graham, Rosalind; Sychowska, Kamila; Seow, Jeffrey; Tremain, Catherine; Gousis, Charalampos; Domingo-Vila, Clara; Cooper, Jack; Vidler, Jennifer; Owczarczyk, Kasia; Swampillai, Angela; Kristeleit, Hartmut; Malim, Michael H; Fields, Paul; Patten, Piers E M; Papa, Sophie; North, Bernard V; Tree, Timothy; Doores, Katie J; Hayday, Adrian C; Irshad, Sheeba.
  • McKenzie DR; The Francis Crick Institute, London, UK.
  • Muñoz-Ruiz M; The Francis Crick Institute, London, UK.
  • Monin L; The Francis Crick Institute, London, UK.
  • Alaguthurai T; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK; Breast Cancer Now Research Unit, King's College London, London, UK.
  • Lechmere T; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
  • Abdul-Jawad S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK.
  • Graham C; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
  • Pollock E; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, UK.
  • Graham R; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK.
  • Sychowska K; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, UK.
  • Seow J; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
  • Tremain C; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Gousis C; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Domingo-Vila C; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, UK.
  • Cooper J; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Vidler J; Department of Haematological Medicine, King's College Hospital, London, UK.
  • Owczarczyk K; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Swampillai A; Breast Cancer Now Research Unit, King's College London, London, UK; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Kristeleit H; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Malim MH; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
  • Fields P; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Patten PEM; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK; Department of Haematological Medicine, King's College Hospital, London, UK.
  • Papa S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • North BV; Clinical Trials Unit, King's College London, UK.
  • Tree T; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, UK.
  • Doores KJ; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
  • Hayday AC; The Francis Crick Institute, London, UK; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, UK.
  • Irshad S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, UK; Breast Cancer Now Research Unit, King's College London, London, UK; Guy's and St. Thomas' NHS Foundation Trust, London, UK; Cancer Research UK (CRUK) Clinician Scientist, London, UK. Electronic addr
Cancer Cell ; 39(11): 1445-1447, 2021 11 08.
Article in English | MEDLINE | ID: covidwho-1482482
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization Schedule / Immunity, Humoral / Spike Glycoprotein, Coronavirus / Immunogenicity, Vaccine / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Immunity, Cellular / Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: J.ccell.2021.10.003

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunization Schedule / Immunity, Humoral / Spike Glycoprotein, Coronavirus / Immunogenicity, Vaccine / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Immunity, Cellular / Neoplasms Type of study: Diagnostic study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2021 Document Type: Article Affiliation country: J.ccell.2021.10.003